Stay updated on Pembrolizumab Plus Entinostat in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page
- Check6 days agoChange DetectedRemoved the Melanoma related topic from the related topics section and deleted the MedlinePlus Genetics related topic (including the related topics header).SummaryDifference0.2%

- Check14 days agoChange DetectedAdded Melanoma as a related topic and MedlinePlus Genetics as a related topic.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.5.0 added. Melanoma and related topics (MedlinePlus Genetics) and Revision: v3.4.3 were removed.SummaryDifference0.2%

- Check35 days agoChange DetectedRevision: v3.4.3 replaces the previous v3.4.2 on the page.SummaryDifference0.1%

- Check42 days agoChange DetectedNo additions or deletions were detected; the page content appears unchanged.SummaryDifference0.1%

- Check64 days agoChange DetectedMelanoma and related topics (MedlinePlus Genetics) were added, and the site revision was updated to v3.4.2 while the prior downtime notice (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Pembrolizumab Plus Entinostat in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.